Advertisement

Advertisement

ADVERTISEMENT

Videos

$Adding Daratumumab to Pomalidomide and Dexamethasone Improves PFS in Relapsed/Refractory MM$

Videos

Adding Daratumumab to Pomalidomide and Dexamethasone Improves PFS in Relapsed/Refractory MM

12/04/2020

12/04/2020

Journal of Clinical Pathways

Using the avoMD Clinical Decision Support App in Practice

Videos

Using the avoMD Clinical Decision Support App in Practice

12/02/2020

12/02/2020

Journal of Clinical Pathways

Next-Gen Clinical Decision Support App for Clinicians at the Point-of-Care

Videos

Next-Gen Clinical Decision Support App for Clinicians at the Point-of-Care

11/30/2020

11/30/2020

Journal of Clinical Pathways

PROs Comparable Between Niraparib, Placebo in Advanced Ovarian Cancer

Videos

PROs Comparable Between Niraparib, Placebo in Advanced Ovarian Cancer

11/29/2020

11/29/2020

Journal of Clinical Pathways

Study Highlights Need to Minimize Health Care Costs in FL

Videos

Study Highlights Need to Minimize Health Care Costs in FL

11/29/2020

Nathan Fowler, MD, MD Anderson Cancer Center, discusses results from a study which explored treatment patterns and health care costs in commercially insured patients with FL.

Nathan Fowler, MD, MD Anderson Cancer Center, discusses results from a study which explored treatment patterns and health care costs in commercially insured patients with FL.

Nathan Fowler, MD, MD Anderson...

11/29/2020

Journal of Clinical Pathways

HRQoL in Newly Diagnosed Ovarian Cancer Treated With Veliparib

Videos

HRQoL in Newly Diagnosed Ovarian Cancer Treated With Veliparib

11/28/2020

11/28/2020

Journal of Clinical Pathways

Integrating Prehabilitation, Rehabilitation, and Prospective Surveillance Into the Cancer Care Continuum

Videos

Integrating Prehabilitation, Rehabilitation, and Prospective Surveillance Into the Cancer Care Continuum

10/08/2020

10/08/2020

Journal of Clinical Pathways

Maintenance Olaparib Improves PFS in BRCA-Mutated, Platinum-Sensitive Ovarian Cancer

Videos

Maintenance Olaparib Improves PFS in BRCA-Mutated, Platinum-Sensitive Ovarian Cancer

07/29/2020

In this video excerpt from Oncology Learning Network, Richard Penson, MD, MRCP, discusses the results from the SOLO2 study which showed that maintenance therapy with the PARP inhibitor led to a...

In this video excerpt from Oncology Learning Network, Richard Penson, MD, MRCP, discusses the results from the SOLO2 study which showed that maintenance therapy with the PARP inhibitor led to a...

In...

07/29/2020

Journal of Clinical Pathways

Specialties

Prostate Cancer

JCP May/June 2024 Issue

Current Issue

June 2024

Volume 10

Issue 3

More Content

Blogs

Popular Articles

Conference Coverage

American Society of Clinical Oncology (ASCO) 2016 Annual Meeting

05/31/2016

Its once again time for the American Society of Clinical Oncology (ASCO) Annual Meeting (June 3-7, 2016; Chicago, IL), which will bring together more than 30,000 oncology professionals from around the world to...

Its once again time for the American Society of Clinical Oncology (ASCO) Annual Meeting (June 3-7, 2016; Chicago, IL), which will bring together more than 30,000 oncology professionals from around the world to...

Its...

05/31/2016

Journal of Clinical Pathways

Editor's Page

For Buy-In of the Clinical Pathways Concept, Transparency Is Key

05/06/2016

Winston Wong, PharmD, Editor-in-Chief

Essential to the success of clinical pathways is transparency of the development process. This includes transparency regarding the clinical evidence reviewed, the economic evaluations made, and the process by which...

Essential to the success of clinical pathways is transparency of the development process. This includes transparency regarding the clinical evidence reviewed, the economic evaluations made, and the process by which...

...

05/06/2016

Journal of Clinical Pathways

Pharma Insights

When Medication Price Deflates Perception of Therapeutic Effect

04/11/2016

Larry Blandford, PharmD—Column Editor

Stephen C Carter

Manufacturers set prices for their products that best represent their value while providing the greatest financial return on investment. Thus, conventional wisdom would suggest that manufacturers set a higher price...

Manufacturers set prices for their products that best represent their value while providing the greatest financial return on investment. Thus, conventional wisdom would suggest that manufacturers set a higher price...

...

04/11/2016

Journal of Clinical Pathways

Research in Review

Report Outlines the Path to Improving Biomarker Tests for Targeted Therapies

03/21/2016

JCP Editors

Biomarker tests are not being adequately used in clinical practice due to a lack of common evidentiary standards for regulatory, reimbursement, and clinical decisions regarding their use, according to a report by the...

Biomarker tests are not being adequately used in clinical practice due to a lack of common evidentiary standards for regulatory, reimbursement, and clinical decisions regarding their use, according to a report by the...

...

03/21/2016

Journal of Clinical Pathways

Research in Review

Costs for High-Risk Patients With ALL Increasing

02/25/2016

JCP Editors

Costs for high-risk pediatric and adolescent patients with acute lymphoblastic leukemia (ALL) may be higher than standard-risk patients with the disease, according to a recent study. While data regarding health care...

Costs for high-risk pediatric and adolescent patients with acute lymphoblastic leukemia (ALL) may be higher than standard-risk patients with the disease, according to a recent study. While data regarding health care...

Costs...

02/25/2016

Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement